Hemolytic assay for the measurement of functional human mannose-binding lectin: A modification to avoid interference from classical pathway activation

Journal of Immunological Methods

Volumn 343, Issue 1, 2009, Pages 61-63

  Herpers, Bjorn L ^a   de Jong, Ben A W ^a   Dekker, Bertie ^b   Aerts, Piet C ^b   van Dijk, Hans ^b   Rijkers, Ger T ^a   van Velzen Blad, Heleen ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anti C1q; Complement; Functional assay; Mannose binding lectin; Modification

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; MANNOSE BINDING LECTIN;

ARTICLE; ARTIFACT; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; HUMAN; IMMUNE STATUS; MEASUREMENT; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; HEMOLYSIS; HUMANS; MANNOSE-BINDING LECTIN;

EID: 60649108184     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.01.002     Document Type: Article

References (11)

1. Frakking F.N., van de Wetering M.D., Brouwer N., Dolman K.M., Geissler J., Lemkes B., Caron H.N., and Kuijpers T.W. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer 42 (2006) 909
2. Garred P., Pressler T., Madsen H.O., Frederiksen B., Svejgaard A., Hoiby N., Schwartz M., and Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104 (1999) 431
3. Hoekzema R., Martens M., Brouwer M.C., and Hack C.E. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q. Mol Immunol 25 (1988) 485
4. Kuipers S., Aerts P.C., Sjoholm A.G., Harmsen T., and van Dijk H. A hemolytic assay for the estimation of functional mannose-binding lectin levels in human serum. J Immunol Methods 268 (2002) 149
5. Madsen H.O., Garred P., Thiel S., Kurtzhals J.A., Lamm L.U., Ryder L.P., and Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155 (1995) 3013
6. Mayer M. In: Kabat E., and Mayer M. (Eds). Experimental Immunochemistry (1961), Thomas, Springfield, IL Ch. 4
7. Roos A., Nauta A.J., Broers D., Faber-Krol M.C., Trouw L.A., Drijfhout J.W., and Daha M.R. Specific inhibition of the classical complement pathway by C1q-binding peptides. J Immunol 167 (2001) 7052
8. Roos A., Bouwman L.H., Munoz J., Zuiverloon T., Faber-Krol M.C., Fallaux-van den Houten F.C., Klar-Mohamad N., Hack C.E., Tilanus M.G., and Daha M.R. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 39 (2003) 655
9. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 17 (1996) 532
10. Turner M.W., and Hamvas R.M. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2 (2000) 305
11. Wiertsema S.P., Herpers B.L., Veenhoven R.H., Salimans M.M., Ruven H.J., Sanders E.A., and Rijkers G.T. Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media. J Allergy Clin Immunol 117 (2006) 1344